Abstract: A novel maize variety designated X7K438 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing maize variety X7K438 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X7K438 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety X7K438, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X7K438. This invention further relates to methods for producing maize varieties derived from maize variety X7K438.

Abstract: A novel maize variety designated 33W82 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing maize variety 33W82 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 33W82 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety 33W82, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety 33W82. This invention further relates to methods for producing maize varieties derived from maize variety 33W82 and to the maize varieties derived by the use of those methods.

Abstract: A method for monitoring execution of a sequence of data processing program instructions in a security module associated to a multimedia unit connected to a managing center supplying control messages authorizing access to broadcast data streams. The security module comprises a processor for executing the instructions, a memory, and a monitoring module for analyzing the instructions before execution by the processor. The managing center comprises a security module emulator generating reference data sets by executing a sequence of instructions induced by data of a given control message in the program. The reference data sets are appended to control messages sent to the security module. The monitoring module analyzes a sequence of program instructions for determining a check data set which is compared with a reference data set received from the control messages. When the reference and check data sets match, the program continues executing. Otherwise, further control message processing stops.

Abstract: The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania, and kits for use with such methods and compositions.

Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.

Abstract: The invention concerns a method for reproducing digital content including the following steps: receiving (E222) an identifier (Id?) of the digital content from a secure electronic entity; extracting (E226) a digital watermark of the digital content; controlling (E232) the reproduction of the content based on a comparison between the extracted watermark and the identifier. The invention concerns a reproducing device, an electronic entity and related systems.

Abstract: The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania, and kits for use with such methods and compositions.

Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.

Abstract: A novel maize variety designated 34Y02 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing maize variety 34Y02 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 34Y02 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety 34Y02, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety 34Y02. This invention further relates to methods for producing maize varieties derived from maize variety 34Y02 and to the maize varieties derived by the use of those methods.

Abstract: The present invention provides vectors that contain and express in vivo or in vitro sand fly Lu. longipalpis salivary antigens that elicit an immune response in animal or human against Leishmania, vaccine compositions comprising said vectors and/or Lu. longipalpis salivary polypeptides, methods of vaccination against Leishmania, and kits for use with such methods and compositions.

Abstract: A novel maize variety designated X6H867 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing maize variety X6H867 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X6H867 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety X6H867, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X6H867. This invention further relates to methods for producing maize varieties derived from maize variety X6H867 and to the maize varieties derived by the use of those methods.

Abstract: A novel maize variety designated X6K239 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing maize variety X6K239 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X6K239 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety X6K239, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X6K239. This invention further relates to methods for producing maize varieties derived from maize variety X6K239 and to the maize varieties derived by the use of those methods.

Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.

Abstract: A method for creating a group signature of a message to be implemented by a member of a group in a system, the system including a trust authority, the group including at least the member provided with a secure portable electronic entity including storage elements and computing elements wherein are implanted a cryptographic algorithm. The method includes the following steps: generating via the computing elements a signature of the message using a private key common to the members of the group and integrating a data identifying the group member and a temporal data representing a temporal information of the member's membership to the group and of the date of the signature of the message, the private key common to the members of the group, the identifying data and the temporal data being stored in the storage elements.

Abstract: The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania, and kits for use with such methods and compositions.

Abstract: An exchange of information between a communication entity e.g. a mobile telephone and the operator server upon which it is dependent, in order to carry out authentication operations by exchanging keys and using cryptography algorithms. According to the invention, an algorithm is used, comprising: algorithmic treatments using, as input data, all or part of a random number and operating keys derived from two keys, and a combined treatment using data derived from algorithmic treatments in order to provide results to enable the linkage.

Abstract: An inbred maize line, designated PH8KG, the plants and seeds of inbred maize line PH8KG, methods for producing a maize plant, either inbred or hybrid, produced by crossing the inbred maize line PH8KG with another maize plant, and hybrid maize seeds and plants produced by crossing the inbred line PH8KG with another maize line or plant and to methods for producing a maize plant containing in its genetic material one or more transgenes and to the transgenic maize plants produced by that method. This invention also relates to inbred maize lines derived from inbred maize line PH8KG, to methods for producing other inbred maize lines derived from inbred maize line PH8KG and to the inbred maize lines derived by the use of those methods.

Abstract: An inbred maize line, designated PH7CP, the plants and seeds of inbred maize line PH7CP, methods for producing a maize plant, either inbred or hybrid, produced by crossing the inbred maize line PH7CP with itself or with another maize plant, and hybrid maize seeds and plants produced by crossing the inbred line PH7CP with another maize line or plant and to methods for producing a maize plant containing in its genetic material one or more transgenes and to the transgenic maize plants produced by that method. This invention also relates to inbred maize lines derived from inbred maize line PH7CP, to methods for producing other inbred maize lines derived from inbred maize line PH7CP and to the inbred maize lines derived by the use of those methods.

Abstract: A method for making secure execution of a computer program includes the following steps: stacking a predetermined value in a pile of instructions of the program; and stack popping the pile, the stack popping step being adapted, as the case may be, to enable detection of an anomalous execution.

Abstract: DNA vaccine against a pathogen affecting farm animals, in particular bovines or porcines, comprising a plasmid containing a nucleotide sequence encoding an immunogen of a pathogen of the animal species considered, under conditions allowing the in vivo expression of this sequence, and a cationic lipid containing a quaternary ammonium salt, of formula in which R1 is a saturated or unsaturated linear aliphatic radical having 12 to 18 carbon atoms, R2 is another aliphatic radical containing 2 or 3 carbon atoms, and X a hydroxyl or amine group, this lipid being preferably DMRIE.